Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 19,998 shares of the business’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $0.78, for a total value of $15,598.44. Following the completion of the transaction, the chief executive officer now owns 919,799 shares […]